Biologics and Biosimilars Congress co-located with Vaccine R&D and Commercialisation Congress Asia 2018

The Biologics & Biosimilar Congress theme will feature cutting-edge research on topics such as modern antibody-based therapeutics & engineering, immunotherapy, and protein biotherapeutics. Also, technological advancements such as antibody-drug conjugates (ADCs), success in monoclonal antibody (Mab) and antibody-derived therapeutics for chronic diseases

For Vaccine, this congress will look into vaccine development, its progression and commercialisation in Asia with leading experts share their insights and strategies that will enable you to fully characterise cell-level immunology, develop effective prognostic and predictive biomarkers, and understand the status of immune system

Get early bird discount :

15% OFF – expiry date 30th Sept : discount code : sk/bbvca18/15

10% OFF – expriry date 31st Oct : discount code : sk/bbvca18/10